1. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer
   Erik Wennerberg et al, 2022, Science Translational Medicine CrossRef
2. MicroRNA‑21: A promising biomarker for the prognosis and diagnosis of non‑small cell lung cancer (Review)
   Wen Zheng et al, 2018, Oncology Letters CrossRef
3. The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
   Luca Antonioli et al, 2019, Pharmacological Reviews CrossRef
4. Tumour immune escape via P2X7 receptor signalling
   Ricardo M. Sainz et al, 2023, Frontiers in Immunology CrossRef
5. Potential role of P2X7R in esophageal squamous cell carcinoma proliferation
   André A Santos et al, 2017, Purinergic Signalling CrossRef
6. Pyrimidinergic receptor P2Y6 expression is elevated in lung adenocarcinoma and is associated with poor prognosis
   Xiuli Wang et al, 2023, Cancer Biomarkers CrossRef
7. Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy
   Wen-jun Zhang, 2021, Purinergic Signalling CrossRef
8. Calcium Channels and Associated Receptors in Malignant Brain Tumor Therapy
   Fernanda B. Morrone et al, 2016, Molecular Pharmacology CrossRef
9. Autocrine and paracrine purinergic signaling in the most lethal types of cancer
   M. Reyna-Jeldes et al, 2021, Purinergic Signalling CrossRef
10. ATP Inhibits Breast Cancer Migration and Bone Metastasis through Down-Regulation of CXCR4 and Purinergic Receptor P2Y11
    Xiaowen Liu et al, 2021, Cancers CrossRef
11. Câncer de pulmão e sistema purinérgico
    Gabriela Matschinski et al, 2021, Sinalização purinérgica: implicações fisiopatológicas CrossRef
12. P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways
    Xue Bai et al, 2023, Purinergic Signalling CrossRef
13. Production, characterization, and application of a monoclonal antibody specific for the extracellular domain of human P2X7R
    Mingxuan Li et al, 2020, Applied Microbiology and Biotechnology CrossRef
14. Purinergic Signalling: Therapeutic Developments
    Geoffrey Burnstock, 2017, Frontiers in Pharmacology CrossRef
15. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
    Geoffrey Burnstock et al, 2018, Purinergic Signalling CrossRef
16. MicroRNA: Crucial modulator in purinergic signalling involved diseases
    Jing Guo et al, 2023, Purinergic Signalling CrossRef
17. Purinergic Receptors: Novel Targets for Cancer Immunotherapy
    Dipti Vijayan et al, 2018, Oncoimmunology CrossRef
18. P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer
    Stephan Ledderose et al, 2023, Cancers CrossRef
19. The P2X7 Receptor
    Ronald Sluyter, 2017, Protein Reviews CrossRef
20. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers
    Xin Wang et al, 2024, European Journal of Cancer Prevention CrossRef
21. MicroRNAs Modulate the Purinergic Signaling Network
    Davide Ferrari et al, 2016, Trends in Molecular Medicine CrossRef
22. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival
    Marina P. Gehring et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef
23. ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer
    Cheng Zuo et al, 2023, European Journal of Medicinal Chemistry CrossRef
24. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
    Qianqian Li et al, 2020, Journal of Cancer Research and Clinical Oncology CrossRef